Three promoters sold 21.5 lakh shares of Innova Captab for ₹234.94 Cr at ₹1092.74 apiece, reducing their combined stake from 21.29% to 17.53%. Gian Parkash Aggarwal - 19,00,000 shares Archit Aggarwal - 1,50,000 shares Veena Devi - 1,00,000 shares
An integrated pharmaceutical company operating across India's drug manufacturing and distribution value chain. Innova Captab develops, manufactures, and markets a diverse portfolio of pharmaceutical formulations for both domestic and international markets. The company maintains vertically integrated operations spanning multiple therapeutic areas, enabling control over production processes, quality management, and supply chain efficiency within the competitive Indian pharmaceutical sector.
